Recently posted guidance documents
7/31/15: Dissolution Testing and Specification Criteria for Immediate-Release Solid Oral Dosage Forms Containing Biopharmaceutics Classification System Class 1 and 3 Drugs Guidance for Industry
8/3/15: FY 2016 Medical Device User Fee Small Business Qualification and Certification - Guidance for Industry, Food and Drug Administration Staff and Foreign Governments
8/3/15: Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act
8/4/15: Refuse to Accept Policy for 510(k)s - Guidance for Industry and Food and Drug Administration Staff
8/4/15: Over-the-Counter Pediatric Oral Liquid Drug Products Containing Acetaminophen
8/5/15: Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs
8/5/15: GFI #220 - Use of Nanomaterials in Food for Animals
8/11/15: Guidance For Entities Considering Whether to Register As Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act
8/3/15: FY 2016 Medical Device User Fee Small Business Qualification and Certification - Guidance for Industry, Food and Drug Administration Staff and Foreign Governments
8/3/15: Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act
8/4/15: Refuse to Accept Policy for 510(k)s - Guidance for Industry and Food and Drug Administration Staff
8/4/15: Over-the-Counter Pediatric Oral Liquid Drug Products Containing Acetaminophen
8/5/15: Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs
8/5/15: GFI #220 - Use of Nanomaterials in Food for Animals
8/11/15: Guidance For Entities Considering Whether to Register As Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act
No hay comentarios:
Publicar un comentario